Paul F. McKenzie

2018

In 2018, Paul F. McKenzie earned a total compensation of $5.7M as Executive Vice President, Pharmaceutical Operations & Technology at Biogen, a 13% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$12,367
Non-Equity Incentive Plan$784,784
Salary$630,455
Stock Awards$4,083,884
Other$154,406
Total$5,665,896

McKenzie received $4.1M in stock awards, accounting for 72% of the total pay in 2018.

McKenzie also received $12.4K of change in pension value and nonqualified deferred compensation earnings, $784.8K in non-equity incentive plan, $630.5K in salary and $154.4K in other compensation.

Rankings

In 2018, Paul F. McKenzie's compensation ranked 1,704th out of 14,244 executives tracked by ExecPay. In other words, McKenzie earned more than 88.0% of executives.

ClassificationRankingPercentile
All
1,704
out of 14,244
88th
Division
Manufacturing
607
out of 5,759
90th
Major group
Chemicals And Allied Products
195
out of 2,122
91st
Industry group
Drugs
155
out of 1,811
91st
Industry
Biological Products, Except Diagnostic Substances
36
out of 339
89th

Pay ratio

Paul F. McKenzie's Pay$5,665,896
Median Employee's Pay$170,521
Pay Ratio

33

to 1

In 2018, the annual total compensation of Paul F. McKenzie was $5,665,896.

The annual total compensation of the median employee at Biogen was $170,521.

The ratio of Paul F. McKenzie's pay to the pay of median employee was therefore 33 to one.

Source: SEC filing on April 30, 2019.

McKenzie's colleagues

We found four more compensation records of executives who worked with Paul F. McKenzie at Biogen in 2018.

2018

Michel Vounatsos

Biogen

Chief Executive Officer

2018

Michael Ehlers

Biogen

Executive Vice President, Research & Development

2018

Susan Alexander

Biogen

Chief Legal Officer

2018

Jeffrey Capello

Biogen

Chief Financial Officer

News

You may also like